$1,116.11
-5.06 (-0.451%)
At Close: Aug 04, 2026
Eli Lilly Takes Another Stab at the Market for Painkillers. This Attempt Might Work.
01:06pm, Tuesday, 16'th Jun 2026
Eli Lilly is acquiring Austin-based 4E Therapeutics, the developer of non-addictive painkillers, for an undisclosed amount.
Eli Lilly vs. Novo Nordisk: Better Obesity Drug Stock?
01:00pm, Tuesday, 16'th Jun 2026
Eli Lilly currently leads the weight loss market. Novo Nordisk's newer launches could help it make up some ground.
Health Care ETFs: XLV Delivers Low Fees and Solid Returns
08:47am, Tuesday, 16'th Jun 2026
Explore how portfolio concentration and stock count set these healthcare ETFs apart, impacting risk and diversification for investors seeking sector exposure.
Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced results from the Phase 3 BRUIN CLL-322 clinical trial of Jaypirca (pirtobrutinib), a
Lilly to present initial clinical data for first-in-class type II JAK2 inhibitor in patients with previously treated myelofibrosis at the 2026
INDIANAPOLIS, June 13, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced new data from the Phase 1 AJX-101 study showing that its investigational type II JAK2 inhibitor (AJ1-11095
Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know
06:45pm, Friday, 12'th Jun 2026
In the closing of the recent trading day, Eli Lilly (LLY) stood at $1, denoting a -2.41% move from the preceding trading day.
Eli Lilly Stock Hits Buy Zone As Earnings Soar 156%. Funds Are Loading Up.
01:01pm, Friday, 12'th Jun 2026
Pharma stock Eli Lilly is trading in a buy zone as institutional investors load up.
Here's Why Eli Lilly (LLY) is a Strong Growth Stock
10:47am, Friday, 12'th Jun 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Forget Eli Lilly and Company: As June Volatility Rocks High-Flyers, This Stock Is a No-Brainer Buy
10:47am, Friday, 12'th Jun 2026
Eli Lilly (NYSE:LLY | LLY Price Prediction) is the stock everyone wants to own right now, a $1.02 trillion obesity juggernaut that has ripped 20.9% higher in a single month on the back of the
American Express, Live Nation And A Health Care Stock: CNBC's 'Final Trades'
07:26am, Friday, 12'th Jun 2026
On CNBC's “Halftime Report Final Trades,” Jenny Van Leeuwen Harrington, CEO of Gilman Hill Asset Management, LLC, picked American Express Company (NYSE:AXP).
Eli Lilly vs Novo Nordisk: The Battle for Obesity Drug Supremacy
02:58pm, Thursday, 11'th Jun 2026
Eli Lilly (NYSE: LLY | LLY Price Prediction) and Novo Nordisk (NYSE: NVO) reported Q1 2026 results that pulled the
Pharma and Biotech M&A Boom Accelerates as Companies Expand Pipelines
02:26pm, Thursday, 11'th Jun 2026
Pharma and biotech dealmaking is surging in 2026 as companies pursue acquisitions to expand pipelines, strengthen portfolios and drive growth.
MU, GOOGL, LLY & Other Stocks Andrew Arons is Watching This Summer
02:00pm, Thursday, 11'th Jun 2026
Andrew Arons discusses summer market equity expectations and stocks he's watching in the current environment. He points to Micron (MU) as one that has much more room to run even after a stellar year-l
Sign In
Buy LLY